January 10, 2019
Holmusk gets residency of Johnson & Johnson Innovation
Holmusk’s team at JLABS @ NYC will focus on building the world’s largest real-world evidence (RWE) platform for behavioral health
Holmusk became a resident company of Johnson & Johnson Innovation, JLABS (JLABS @ NYC), a premier life science incubator program. With its residency, Holmusk is excited to interact with other resident companies and looks forward to expanding its US footprint and deepening its relationship with partners and stakeholders within the pharma/life science hub of the US east coast.
Holmusk’s team at JLABS @ NYC will focus on building the world’s largest real-world evidence (RWE) platform for behavioral health. This platform will incorporate the latest evidence from clinical trials and real-world data, brining insights to the point of care. Additionally, the platform will serve as a stepping stone to drive innovation among pharma companies to serve patients with unmet needs and allow quicker access to new drugs.
[Originally posted by BioSpectrum— January 8, 2019]